Stock analysis Venus Remedies Limited VENUSREM
More indepth analysis on MunafaSutra.com
Recent prices of VENUSREM Venus Remedies Limited are as follows: Daily volume is divided by 10 day averaged volume
Date | Close | Range | Change % | Volume |
03 Mon Feb 2025 | 288.35 | 285.55 to 296.10 | -4.14% | 1.29 times |
31 Fri Jan 2025 | 300.80 | 292.15 to 304.00 | 1.67% | 0.34 times |
30 Thu Jan 2025 | 295.85 | 291.90 to 302.45 | 1.42% | 0.31 times |
29 Wed Jan 2025 | 291.70 | 271.85 to 295.00 | 5.73% | 0.89 times |
28 Tue Jan 2025 | 275.90 | 270.25 to 291.75 | -3.57% | 0.95 times |
27 Mon Jan 2025 | 286.10 | 284.30 to 292.15 | -2.05% | 0.51 times |
24 Fri Jan 2025 | 292.10 | 291.00 to 298.00 | -0.68% | 0.42 times |
23 Thu Jan 2025 | 294.10 | 292.20 to 297.95 | 0.03% | 0.46 times |
22 Wed Jan 2025 | 294.00 | 291.25 to 303.85 | -2.37% | 0.72 times |
21 Tue Jan 2025 | 301.15 | 299.65 to 332.40 | 1.96% | 5.02 times |
20 Mon Jan 2025 | 295.35 | 294.15 to 300.05 | -0.81% | 0.39 times |
17 Fri Jan 2025 | 297.75 | 295.95 to 301.40 | -0.55% | 0.23 times |
Technical analysis forecast for Venus Remedies Limited Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Venus Remedies Limited VENUSREM at this time. Stock is falling and might fall more.
It appears as if Venus Remedies Limited VENUSREM gave a large move recently.
Stock of Venus Remedies Limited (VENUSREM) is trading below an important moving average line, but it crossed this line recently, which means that it could show a small or a large recovery soon enough depending on its trend.
My analysis of Venus Remedies Limited is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if Venus Remedies Limited stays below 289.7, but if it comes above 289.7, then a intra day buy could be more profitable.
If you take a sell trade below 289.7, then use 289.7 as stoploss and 282.3 as target. However if you take a buy trade in Venus Remedies Limited, then use 289.7 as stoploss and 295.89 as target.